Thyrocare Technologies Limited (THYROCARE.BO)
INR 980.85
(-1.19%)
INR 980.85
(-1.19%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.64 Billion | 1.29 Billion | 1.13 Billion | 1.14 Billion | 1.67 Billion | 1 Billion |
| Net Income | 707.6 Million | 874.1 Million | 2.27 Billion | 1.52 Billion | 1.46 Billion | 1.37 Billion |
| Depreciation & Amortization | 470.1 Million | 387.1 Million | 338.7 Million | 302.8 Million | 319.1 Million | 261.7 Million |
| Deferred income taxes | - | -247.4 Million | -731.2 Million | -522.2 Million | -474.4 Million | -653.3 Million |
| Stock-based compensation | 166.7 Million | 211.7 Million | 23.2 Million | 16.8 Million | 20 Million | 19.3 Million |
| Change in working capital | 301.6 Million | 57.9 Million | -792.2 Million | -176.5 Million | 337.8 Million | -6.5 Million |
| Other non-cash items | 814 Million | 9.7 Million | 16.6 Million | 1 Million | 11.5 Million | 7.9 Million |
| Investing Cash Flow | -910.6 Million | -389.9 Million | -235.7 Million | -486.6 Million | 9.5 Million | -115.9 Million |
| Investments in PPE | -615.9 Million | -436.5 Million | -378.3 Million | -266.9 Million | -99 Million | -402.5 Million |
| Acquisitions | 19.3 Million | 30.2 Million | 42.5 Million | 42.5 Million | 300 Thousand | 13.4 Million |
| Investment purchases | -314 Million | -1.91 Billion | -1.73 Billion | -1.36 Billion | -1.32 Billion | -1.15 Billion |
| Sales/Maturities of investments | - | 1.93 Billion | 1.59 Billion | 1.04 Billion | 1.42 Billion | 1.4 Billion |
| Other Investing Activities | -297 Million | 3.8 Million | 236.6 Million | 56.8 Million | 7.6 Million | 17.9 Million |
| Financing Cash Flow | -818.1 Million | -861.8 Million | -894.1 Million | -615.8 Million | -1.64 Billion | -936.3 Million |
| Debt repayment | -216 Million | -55.3 Million | -53.8 Million | -25 Million | -43.9 Million | -17.1 Million |
| Dividends payments | -952.7 Million | -793.5 Million | -793.1 Million | -528.4 Million | -1.59 Billion | -268.6 Million |
| Common Stock Repurchased | - | -55.3 Million | -53.8 Million | -62.6 Million | -14.3 Million | -630 Million |
| Common Stock Issuance | 200 Thousand | 300 Thousand | 300 Thousand | 300 Thousand | 400 Thousand | 400 Thousand |
| Other Financing Activities | 12.1 Million | 42 Million | 6.3 Million | -100 Thousand | -270.4 Million | -21 Million |
| Accounts receivables | 328.2 Million | -14.3 Million | -587.2 Million | -288.1 Million | -60.3 Million | -27.9 Million |
| Accounts payables | 161.2 Million | 74.2 Million | -84.8 Million | 31.5 Million | 143.5 Million | 9.1 Million |
| Inventory | -198.5 Million | -31.4 Million | -11.7 Million | -27.4 Million | -25.4 Million | -10.3 Million |
| Other working capital | 10.7 Million | 29.4 Million | -108.5 Million | 107.5 Million | 280 Million | 22.6 Million |
| Cash at beginning of period | 177.7 Million | 136.3 Million | 132 Million | 87.1 Million | 49.1 Million | 98.2 Million |
| Cash at end of period | 398.9 Million | 177.7 Million | 136.3 Million | 132 Million | 89.6 Million | 49.1 Million |
| Capital Expenditure | -615.9 Million | -436.5 Million | -378.3 Million | -266.9 Million | -99 Million | -402.5 Million |
| Effect of forex changes on cash | - | - | - | -2.5 Million | - | - |
| Net cash flow / Change in cash | 221.2 Million | 41.4 Million | 4.3 Million | 44.9 Million | 40.5 Million | -49.1 Million |
| Free Cash Flow | 1.02 Billion | 856.6 Million | 755.8 Million | 880.4 Million | 1.57 Billion | 600.6 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 241.7 Million | 707.6 Million | 177.8 Million | 153.5 Million | 203.4 Million | 173 Million |
| Depreciation & Amortization | - | 470.1 Million | - | 134.7 Million | 106.5 Million | 98.3 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 166.7 Million | 166.7 Million | - | - | - |
| Change in working capital | - | 301.6 Million | - | - | - | - |
| Other non-cash items | -241.7 Million | 814 Million | -344.5 Million | -153.5 Million | -203.4 Million | -173 Million |
| Investing Cash Flow | - | -910.6 Million | - | - | - | - |
| Investments in PPE | - | -615.9 Million | - | - | - | - |
| Acquisitions | - | 19.3 Million | - | - | - | - |
| Investment purchases | - | -314 Million | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -297 Million | - | - | - | - |
| Financing Cash Flow | - | -818.1 Million | - | - | - | - |
| Debt repayment | - | -216 Million | - | - | - | - |
| Dividends payments | - | -952.7 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 200 Thousand | - | - | - | - |
| Other Financing Activities | - | 12.1 Million | - | - | - | - |
| Accounts receivables | - | 328.2 Million | - | - | - | - |
| Accounts payables | - | 161.2 Million | - | - | - | - |
| Inventory | - | -198.5 Million | - | - | - | - |
| Other working capital | - | 10.7 Million | - | - | - | - |
| Cash at beginning of period | - | 177.7 Million | - | 146.7 Million | -66.3 Million | 177.7 Million |
| Cash at end of period | - | 398.9 Million | - | 416.1 Million | 146.7 Million | 374.3 Million |
| Capital Expenditure | - | -615.9 Million | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | 221.2 Million | - | 269.4 Million | 213 Million | 196.6 Million |
| Free Cash Flow | - | 1.02 Billion | - | 269.4 Million | 213 Million | 196.6 Million |
SAKHTISUG
INS
002099
5966
GODREJAGRO
TEAMLEASE